Observational studyMedicine2018

Unprotected versus protected high-risk percutaneous coronary intervention with the Impella 2.5 in patients with multivessel disease and severely reduced left ventricular function.

Tobias Becher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.